These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11296593)

  • 1. Possible short-term amelioration of basilar plaque by high-dose atorvastatin: use of reductase inhibitors for intracranial plaque stabilization.
    Callahan AS; Berger BL; Beuter MJ; Devlin TG
    J Neuroimaging; 2001 Apr; 11(2):202-4. PubMed ID: 11296593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic intracranial arterial stenosis: a single-center, randomized, single-blind, parallel-group study with one-year follow-up.
    Zhou P; Lu Z; Gao P; Wang P; Cao Z; Zhang G; Wang S; Feng Y; Wang P
    Clin Neurol Neurosurg; 2014 May; 120():6-13. PubMed ID: 24731567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipid-lowering therapy on the progression of intracranial arterial stenosis.
    Tan TY; Kuo YL; Lin WC; Chen TY
    J Neurol; 2009 Feb; 256(2):187-93. PubMed ID: 19271101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis.
    Takayama T; Hiro T; Ueda Y; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
    J Cardiol; 2013 Jun; 61(6):381-6. PubMed ID: 23478121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amlodipine + atorvastatin single pill is the most effective choice for primary prevention.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(4):243. PubMed ID: 20838732
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
    Goldstein MR; Mascitelli L; Pezzetta F
    Neurology; 2009 Apr; 72(16):1448; author reply 1448-9. PubMed ID: 19380709
    [No Abstract]   [Full Text] [Related]  

  • 7. Atorvastatin treatment and vaccination efficacy.
    Packard RR; Schlegel S; Senouf D; Burger F; Sigaud P; Perneger T; Siegrist CA; Mach F
    J Clin Pharmacol; 2007 Aug; 47(8):1022-7. PubMed ID: 17548534
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I.
    Crouse JR; Frohlich J; Ose L; Mercuri M; Tobert JA
    Am J Cardiol; 1999 May; 83(10):1476-7, A7. PubMed ID: 10335764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In addition to atorvastatin. Innovative antibody lowers LDL around 72%].
    Einecke D
    MMW Fortschr Med; 2012 Apr; 154(7):28. PubMed ID: 22558865
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rhabdomyolysis associated to combined ezetimibe-statin treatment].
    Piedra León M; García Unzueta MT; Otero Martínez M; Amado Señaris JA
    Rev Clin Esp; 2007 Sep; 207(8):425-6. PubMed ID: 17688879
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    van der Harst P; Voors AA; van Veldhuisen DJ
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15306676
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose atorvastatin therapy achieves 25% reduction in CV events in TNT substudy of diabetic patients.
    Cardiovasc J S Afr; 2006; 17(4):206-7. PubMed ID: 17001426
    [No Abstract]   [Full Text] [Related]  

  • 13. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
    J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. By the way, doctor... My brother takes Mevacor and has been told to take the drug at bedtime. But when I started on Lipitor, my doctor said to take the medication at any time of the day. Why the difference?
    Lee TH
    Harv Health Lett; 2001 Aug; 26(10):8. PubMed ID: 11546623
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Gotto AM
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309745
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Paradis JM; LeLorier J
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309744
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Miller M
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309746
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
    Patti G; Pasceri V; Nusca A; Di Sciascio G
    Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Auer J; Weber T; Eber B
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309747
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P; Kafonek S; Laurora I; Hunninghake D
    Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.